Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer

Fig. 4

Biocompatibility of A6-NP. (A) Hemolysis test of fabricated nanoparticles. (B) Hemolysis ratio of fabricated nanoparticles. (C) Cell viabilities of blank nanoparticles in HUVECs (n = 3). (D) Cell viabilities of blank nanoparticles in MOLM13 cells (n = 3). (E) Cell viabilities of blank nanoparticles in HCT116 cells (n = 3)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us